Trial Profile
A Randomized, Single Blind, Placebo Controlled, Multicenter Study to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 22 Apr 2021
Price :
$35
*
At a glance
- Drugs Polidocanol (Primary)
- Indications Varicose veins
- Focus Therapeutic Use
- Acronyms Pilot
- Sponsors BTG International
- 24 Sep 2014 New trial record